Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study.
about
Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockadeAndrogen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcificationTestosterone for the aging male; current evidence and recommended practiceThe benefits and risks of testosterone replacement therapy: a reviewAndrogen actions on endothelium functions and cardiovascular diseasesVascular calcification and fracture riskTestosterone and the cardiovascular system: a comprehensive review of the clinical literaturePolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenIn vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular systemImpact of Diet-Induced Obesity and Testosterone Deficiency on the Cardiovascular System: A Novel Rodent Model Representative of Males with Testosterone-Deficient Metabolic Syndrome (TDMetS)Testosterone replacement therapy: current trends and future directionsPatient satisfaction with testosterone replacement therapies: the reasons behind the choicesTestosterone and vascular function in agingTime-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels.Welcoming low testosterone as a cardiovascular risk factorExtremes of endogenous testosterone are associated with increased risk of incident coronary events in older women.Modulation of neointimal lesion formation by endogenous androgens is independent of vascular androgen receptor.Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women.The relationship between level of androgenic hormones and coronary artery disease in men.Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndromeSingle-nucleotide polymorphism, rs1799941 in the Sex Hormone-Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in men: the Tromsø Study.Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation.Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial.Sex hormone levels in patients with sudden cardiac arrest.Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study.Testosterone deficiency and cardiovascular mortality.Relationship between Serum Testosterone and Cardiovascular Disease Risk Determined Using the Framingham Risk Score in Male Patients with Sexual Dysfunction.Effect of testosterone deficiency on cholesterol metabolism in pigs fed a high-fat and high-cholesterol diet.Fatherhood and the risk of cardiovascular mortality in the NIH-AARP Diet and Health Study.Testosterone replacement and cardiovascular safety: no straight and narrow!Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of lifeTestosterone metabolism, dose-response relationships and receptor polymorphisms: selected pharmacological/toxicological considerations on benefits versus risks of testosterone therapy in men.Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable Testosterone.Common Variants in Promoter of ADTRP Associate with Early-Onset Coronary Artery Disease in a Southern Han Chinese PopulationConnecting the Lines between Hypogonadism and Atherosclerosis.Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.Preventing diseases of the prostate in the elderly using hormones and nutriceuticals.Testosterone and the metabolic syndrome.Endogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein receptor-deficient mice.Low serum testosterone and mortality in older men.
P2860
Q22306443-0F32FC43-7B16-4E61-BC59-1685425F29BAQ24293731-DEE117D6-F6F0-44FC-8C86-629C177EEBB7Q24647679-5B0EEDD0-6A62-472A-A51D-ABBE1DA80AE1Q24658011-48842ACD-FF0A-440A-984C-2F3FBBBAA3D9Q26750657-DAFEFDC0-1934-4C14-BA1C-38001BB7981CQ26775755-B0D4AEA9-97FA-4840-BD73-E8469B72E222Q27000507-E0027679-5F33-4582-83D1-B47768005A40Q27021307-9E574529-EA09-40DC-8525-4EAE6468683AQ27026337-30836AD7-C82D-46E5-8206-EA17A90F480CQ27318055-32267D96-A5FE-49E6-A093-972A03CC9153Q28275913-68DD4985-039C-4E4A-A461-F7893B218427Q28304192-9A6A4D5E-04B2-4684-B5BD-29ACB468AA47Q28383213-CD8CBEDD-12DE-4B5D-AF32-2CE660A5273AQ33621446-069F57F0-B861-4AA9-9CA1-798877865809Q33710349-8CEB5D14-E9F6-480C-8CF8-34F970D41878Q33736113-68758CC9-A4C6-484F-B72A-2F94353B2A97Q33890595-83A149D3-560D-4787-BCD6-BCC5F146A53DQ34196350-D1FFAF3D-C38F-42A2-824D-C434B4714920Q34221162-45779734-2821-40F4-864F-58D336099456Q34227893-192FECA2-A369-4B90-98CC-F196BAB39DB8Q34391105-DA01B3CF-724E-404B-8140-5E861D3A05AFQ34471171-A549591C-E205-41E3-BB5D-C2930B5B2911Q34578422-E2FE5307-1C6C-4DE9-8EFF-4753F08A2E9AQ34620130-219F776A-A643-4C42-8610-A53BE2D24F3DQ34700340-E7DADD68-ED22-4BBD-920D-1C4D1A899F94Q34927884-E7735E57-D4F1-45B3-A9F4-D8278CD590B8Q34984090-9B3B3E60-9A48-438E-9FF2-A83C1372A643Q35170131-E62BE372-189C-4C14-9282-E5E42DB031F2Q35540537-BFB426DE-FDB5-4410-80FD-5D0C281BA5A9Q35546614-8868D673-00B1-4AB5-A1BC-03EE902E573EQ35582685-ABF34FAE-F1CB-49A1-91CA-E3F8D738159AQ35684578-AA8A52DC-7BD9-43ED-97A5-0F179CA5D3C9Q35739697-7CDA793D-6767-42C8-BCCB-CC5F77BA0B1DQ35777270-5E18C7F6-CAD3-4988-9AC9-8FE021AD0EFDQ35810628-F0C4A53A-B19A-408B-B191-6220E66D0A78Q35852422-04AA98A8-5D6F-4DBB-8571-0323B280224BQ36021075-46A077D0-A531-48CB-A493-CBF968467F68Q36327973-0820FB32-419E-42E4-AA2D-82162DCAC80CQ36353275-356ABF89-6F48-4B8F-A9AC-A9C743A43BA8Q36360750-840EF263-E0F1-4654-B2B9-FADF4F7F5DA0
P2860
Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Low levels of endogenous andro ...... erly men: the Rotterdam study.
@en
Low levels of endogenous andro ...... erly men: the Rotterdam study.
@nl
type
label
Low levels of endogenous andro ...... erly men: the Rotterdam study.
@en
Low levels of endogenous andro ...... erly men: the Rotterdam study.
@nl
prefLabel
Low levels of endogenous andro ...... erly men: the Rotterdam study.
@en
Low levels of endogenous andro ...... erly men: the Rotterdam study.
@nl
P2093
P356
P1476
Low levels of endogenous andro ...... erly men: the Rotterdam study.
@en
P2093
A Elisabeth Hak
Frank H de Jong
Huibert A P Pols
Jacqueline C M Witteman
Mirjam I Geerlings
P304
P356
10.1210/JCEM.87.8.8762
P407
P577
2002-08-01T00:00:00Z